We know that pharmacyte is raising funds for the trial and need about 10 million so it's no surprise if the pps is stuck at 12. A bit below twelve and the company loses the right to sell shares as the valuation slips below 75 million.
But is there something else happening too. I can't see level 2?
I suspect that over 12 at this stage of the company's development with 1 million shares now costing 120,000usd there are fewer and fewer investors wanting to jump in.